MorphoSys AG MOR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:35 AM EDT
18.37quote price arrow up+0.07 (+0.38%)
Volume
28,359
52 week range
4.18 - 19.50
Loading...
  • Open18.28
  • Day High18.50
  • Day Low18.28
  • Prev Close18.30
  • 52 Week High19.50
  • 52 Week High Date05/16/24
  • 52 Week Low4.18
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap2.771B
  • Shares Out150.87M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change85.56

KEY STATS

  • Open18.28
  • Day High18.50
  • Day Low18.28
  • Prev Close18.30
  • 52 Week High19.50
  • 52 Week High Date05/16/24
  • 52 Week Low4.18
  • 52 Week Low Date11/22/23
  • Market Cap2.771B
  • Shares Out150.87M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change85.56

RATIOS/PROFITABILITY

  • EPS (TTM)-3.38
  • P/E (TTM)-5.43
  • Fwd P/E (NTM)-4.20
  • EBITDA (TTM)-468.399M
  • ROE (TTM)-183.80%
  • Revenue (TTM)220.878M
  • Gross Margin (TTM)83.89%
  • Net Margin (TTM)-224.25%
  • Debt To Equity (MRQ)-99.76%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MorphoSys AG

 

Profile

MORE
MorphoSys AG is a global commercial-stage biopharmaceutical company based in Germany. The Company discovers, develops, and delivers cancer medicines to patients. It markets its proprietary medicine Monjuvi (tafasitamab-cxix) in the United States, a cancer immunotherapy treatment, used to treat patients in combination with lenalidomide with second and later lines of diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant. Tafasitamab is...
Lucinda Crabtree Ph.D.
Chief Financial Officer, Member of the Executive Committee
Address
Semmelweisstr. 7
Planegg
82152
Germany

Top Peers

SYMBOLLASTCHG%CHG
ACLX
Arcellx Inc
53.38-0.88-1.62%
TWST
Twist Bioscience Corp
42.22-0.87-2.02%
DNLI
Denali Therapeutics Inc
19.53-0.53-2.64%
VCEL
Vericel Corp
50.13-0.20-0.40%
IMCR
Immunocore Holdings PLC
49.00-1.47-2.91%